TITLE:
Role of Intratympanic Steroids in the Management of Idiopathic Sudden Sensori Neural Hearing Loss— Our Experience of 67 Cases
AUTHORS:
D. S. Deenadayal, D. Vidyasagar, Vyshanavi Bommakanti, Madisetty Naveen Kumar, Nakirikanti Ravi Kumar, Ramesh Chintha
KEYWORDS:
Intratympanic Methyl Prednisolone, Sudden Sensorineural Hearing Loss
JOURNAL NAME:
International Journal of Otolaryngology and Head & Neck Surgery,
Vol.5 No.4,
July
21,
2016
ABSTRACT: Objective: To assess the outcomes of intratympanic steroids in the management of idiopathic
sudden sensorineural hearing loss. Study Design: Retrospective study. Setting: Academic tertiary
care medical centre. Materials and Methods: A total of 67 patients with idiopathic sudden sensorineural
hearing loss were included in our study. Pre- and post-injection audiograms were
taken to assess the outcomes in improvement in hearing. Hearing outcomes were assessed with
respect to duration of onset of treatment and age of the patient. Improvement in the speech discrimination
score was also assessed. Results: A total of 67 patients were included in our study of
which unilateral cases were 59 and bilateral cases were 8. Subjectively 35 patients reported improvement
in hearing after the therapy while objectively we found 44 ears [41 patients] had improvement.
The mean PTA pre ITS was 62.7 and after ITS it was 56.3. Maximum improvement was
noted at 2000 Hz and 1000 Hz. Conclusion: Intratympanic steroids can be offered as a first line
therapy for idiopathic sudden sensorineural hearing loss as it is minimally invasive, and can be
performed as an office based procedure with no systemic side effects. No major complications
have been reported in our study and results have been satisfactory.